play_arrow

keyboard_arrow_right

Listeners:

Top listeners:

skip_previous skip_next
00:00 00:00
playlist_play chevron_left
volume_up

GlaxoSmithKline

1 Result / Page 1 of 1

Background

Health / Medical

Shares slump for drugmaker GSK on Zantac ruling

      Shares in British pharmaceutical group GSK tumbled Monday after a US court paved the way for legal action by tens of thousands of patients who allege the heartburn drug Zantac caused cancer. The over-the-counter treatment, known also by its non-commercial name ranitidine, was manufactured by several rivals including the French group Sanofi and US drugmaker Pfizer before it was withdrawn in 2019. "GSK disagrees with the ruling […]

todayJune 3, 2024 20

0%